Abroi A, Kurg R, Ustav M
Department of Microbiology and Virology, Tartu University and Estonian Biocentre, Estonia.
J Virol. 1996 Sep;70(9):6169-79. doi: 10.1128/JVI.70.9.6169-6179.1996.
A set of E2 proteins with mutations in the amino-terminal transactivation domain was made by a scheme called clustered charged-to-alanine scan. These mutant E2 proteins were tested for expression, stability, and compartmentalization in cells and for sequence-specific DNA binding, as well as in functional assays for transcriptional and replicational activation. We identified four groups of mutants. First, mutants K111A, K112A, and E176A were unable to activate replication and transcription because of oligomerization-induced retention of oligomers in the cytoplasm. Second, although fractions of the mutant proteins E74A and D143A/ R172C existed in the oligomeric form, they were localized in the nucleus. Certain fractions of these proteins existed as a dimer able to form a specific complex and activate replication; however, these proteins were inactive in transcriptional activation. Third, mutants R37A and D122A were localized in the nucleus, existed in the dimeric form, supported replication efficiently, and were severely crippled in transcriptional activation. The fourth group of mutants did not differ considerably from the wild-type protein. The activation of transcription by the wild type as well as mutant E2 proteins was dependent on the concentration of input E2 expression vector DNA and had a bell-like shape. We suggest that the reduction of transcriptional activation at higher E2 concentrations, the self-squelching activity, is caused by oligomerization of the E2 transactivator and is one of the mechanisms for the regulation of E2 activity. Our results also show that transcriptional and replicational activation activities are encoded by different determinants in the E2 protein.
通过一种称为成簇电荷到丙氨酸扫描的方案制备了一组在氨基末端反式激活结构域中具有突变的E2蛋白。对这些突变的E2蛋白进行了细胞中的表达、稳定性和区室化测试,以及序列特异性DNA结合测试,还进行了转录和复制激活的功能测定。我们鉴定出了四组突变体。第一,突变体K111A、K112A和E176A由于寡聚化诱导寡聚体滞留于细胞质中而无法激活复制和转录。第二,尽管突变蛋白E74A和D143A/R172C的部分以寡聚体形式存在,但它们定位于细胞核中。这些蛋白的某些部分以能够形成特异性复合物并激活复制的二聚体形式存在;然而,这些蛋白在转录激活中无活性。第三,突变体R37A和D122A定位于细胞核中,以二聚体形式存在,能有效支持复制,并且在转录激活中严重受损。第四组突变体与野生型蛋白没有显著差异。野生型以及突变型E2蛋白的转录激活取决于输入E2表达载体DNA的浓度,呈钟形。我们认为,在较高E2浓度下转录激活的降低,即自我抑制活性,是由E2反式激活因子的寡聚化引起的,并且是E2活性调节机制之一。我们的结果还表明,转录和复制激活活性由E2蛋白中的不同决定因素编码。